Structure

Physi-Chem Properties

Molecular Weight:  330.15
Volume:  345.563
LogP:  3.291
LogD:  3.311
LogS:  -5.354
# Rotatable Bonds:  6
TPSA:  65.74
# H-Bond Aceptor:  5
# H-Bond Donor:  0
# Rings:  2
# Heavy Atoms:  5

MedChem Properties

QED Drug-Likeness Score:  0.456
Synthetic Accessibility Score:  2.78
Fsp3:  0.368
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Rejected
GSK Rule:  Accepted
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.761
MDCK Permeability:  1.8154312783735804e-05
Pgp-inhibitor:  0.961
Pgp-substrate:  0.003
Human Intestinal Absorption (HIA):  0.007
20% Bioavailability (F20%):  0.007
30% Bioavailability (F30%):  0.908

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.125
Plasma Protein Binding (PPB):  86.11766052246094%
Volume Distribution (VD):  0.956
Pgp-substrate:  8.29045581817627%

ADMET: Metabolism

CYP1A2-inhibitor:  0.878
CYP1A2-substrate:  0.972
CYP2C19-inhibitor:  0.844
CYP2C19-substrate:  0.651
CYP2C9-inhibitor:  0.808
CYP2C9-substrate:  0.869
CYP2D6-inhibitor:  0.682
CYP2D6-substrate:  0.715
CYP3A4-inhibitor:  0.649
CYP3A4-substrate:  0.266

ADMET: Excretion

Clearance (CL):  10.459
Half-life (T1/2):  0.539

ADMET: Toxicity

hERG Blockers:  0.012
Human Hepatotoxicity (H-HT):  0.62
Drug-inuced Liver Injury (DILI):  0.784
AMES Toxicity:  0.233
Rat Oral Acute Toxicity:  0.146
Maximum Recommended Daily Dose:  0.399
Skin Sensitization:  0.409
Carcinogencity:  0.198
Eye Corrosion:  0.005
Eye Irritation:  0.358
Respiratory Toxicity:  0.921

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC268081

Natural Product ID:  NPC268081
Common Name*:   5,7-Dimethoxy-8-[(E)-2-Methylbut-2-Enoyl]-4-Propylchromen-2-One
IUPAC Name:   5,7-dimethoxy-8-[(E)-2-methylbut-2-enoyl]-4-propylchromen-2-one
Synonyms:  
Standard InCHIKey:  HJTTYQGWKFPWJE-YRNVUSSQSA-N
Standard InCHI:  InChI=1S/C19H22O5/c1-6-8-12-9-15(20)24-19-16(12)13(22-4)10-14(23-5)17(19)18(21)11(3)7-2/h7,9-10H,6,8H2,1-5H3/b11-7+
SMILES:  CCCc1cc(=O)oc2c1c(cc(c2C(=O)/C(=C/C)/C)OC)OC
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL462675
PubChem CID:   6474785
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000261] Phenylpropanoids and polyketides
      • [CHEMONTID:0000145] Coumarins and derivatives

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO17406 Calophyllum lanigerum Species Calophyllaceae Eukaryota n.a. Sarawak, Malaysia n.a. PMID[11430019]
NPO17406 Calophyllum lanigerum Species Calophyllaceae Eukaryota n.a. n.a. n.a. PMID[1379639]
NPO19800 Calophyllum teysmannii Species Calophyllaceae Eukaryota n.a. n.a. n.a. PMID[8792623]
NPO17406 Calophyllum lanigerum Species Calophyllaceae Eukaryota n.a. n.a. n.a. PMID[8792623]
NPO19800 Calophyllum teysmannii Species Calophyllaceae Eukaryota n.a. latex n.a. PMID[8864237]
NPO19800 Calophyllum teysmannii Species Calophyllaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO19800 Calophyllum teysmannii Species Calophyllaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO17406 Calophyllum lanigerum Species Calophyllaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO19800 Calophyllum teysmannii Species Calophyllaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT759 Cell Line H9 Homo sapiens IC50 = 1000.0 nM PMID[507332]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC268081 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9924 High Similarity NPC253616
0.9699 High Similarity NPC36414
0.9627 High Similarity NPC472515
0.9478 High Similarity NPC38153
0.9403 High Similarity NPC472516
0.9394 High Similarity NPC229646
0.9338 High Similarity NPC136095
0.9338 High Similarity NPC473209
0.9333 High Similarity NPC103001
0.9328 High Similarity NPC46869
0.9308 High Similarity NPC473907
0.9281 High Similarity NPC171656
0.927 High Similarity NPC470856
0.9259 High Similarity NPC174999
0.9259 High Similarity NPC161196
0.9237 High Similarity NPC473894
0.9231 High Similarity NPC49852
0.9231 High Similarity NPC475496
0.9197 High Similarity NPC262635
0.9191 High Similarity NPC474624
0.9191 High Similarity NPC131782
0.9191 High Similarity NPC138047
0.9191 High Similarity NPC332594
0.9143 High Similarity NPC294365
0.9143 High Similarity NPC469953
0.9137 High Similarity NPC36181
0.913 High Similarity NPC16455
0.913 High Similarity NPC307990
0.9124 High Similarity NPC219584
0.9124 High Similarity NPC199458
0.9124 High Similarity NPC470083
0.9124 High Similarity NPC17848
0.9124 High Similarity NPC131130
0.9124 High Similarity NPC183639
0.9118 High Similarity NPC254741
0.9111 High Similarity NPC66705
0.9111 High Similarity NPC125920
0.9104 High Similarity NPC54503
0.9104 High Similarity NPC473655
0.9104 High Similarity NPC101294
0.9104 High Similarity NPC55147
0.9091 High Similarity NPC191104
0.9078 High Similarity NPC154217
0.9078 High Similarity NPC470322
0.9078 High Similarity NPC473927
0.9071 High Similarity NPC87609
0.9071 High Similarity NPC470296
0.9071 High Similarity NPC196459
0.9071 High Similarity NPC112791
0.9071 High Similarity NPC94794
0.9071 High Similarity NPC188632
0.9065 High Similarity NPC103362
0.9065 High Similarity NPC110969
0.9065 High Similarity NPC254010
0.9065 High Similarity NPC201820
0.9058 High Similarity NPC139554
0.9058 High Similarity NPC19476
0.9058 High Similarity NPC11566
0.9058 High Similarity NPC241975
0.9058 High Similarity NPC23257
0.9051 High Similarity NPC259685
0.9051 High Similarity NPC157855
0.9044 High Similarity NPC60667
0.9037 High Similarity NPC108113
0.9037 High Similarity NPC93756
0.9037 High Similarity NPC292998
0.9037 High Similarity NPC247743
0.903 High Similarity NPC284424
0.903 High Similarity NPC278556
0.9021 High Similarity NPC88445
0.9014 High Similarity NPC218300
0.9014 High Similarity NPC180477
0.9014 High Similarity NPC282335
0.9007 High Similarity NPC469935
0.9007 High Similarity NPC1886
0.9007 High Similarity NPC178627
0.9007 High Similarity NPC196137
0.9 High Similarity NPC470556
0.9 High Similarity NPC112829
0.9 High Similarity NPC294432
0.9 High Similarity NPC226636
0.9 High Similarity NPC11561
0.9 High Similarity NPC313036
0.8993 High Similarity NPC221173
0.8993 High Similarity NPC241100
0.8993 High Similarity NPC172986
0.8993 High Similarity NPC261227
0.8993 High Similarity NPC472409
0.8993 High Similarity NPC471587
0.8993 High Similarity NPC474037
0.8993 High Similarity NPC150522
0.8993 High Similarity NPC159275
0.8993 High Similarity NPC270883
0.8986 High Similarity NPC470669
0.8986 High Similarity NPC470668
0.8978 High Similarity NPC156910
0.8971 High Similarity NPC61499
0.8971 High Similarity NPC125269
0.8971 High Similarity NPC229128
0.8963 High Similarity NPC10971
0.8958 High Similarity NPC474660
0.8958 High Similarity NPC180351
0.8951 High Similarity NPC266743
0.8947 High Similarity NPC211120
0.8944 High Similarity NPC57470
0.8944 High Similarity NPC181388
0.8939 High Similarity NPC37512
0.8936 High Similarity NPC184738
0.8936 High Similarity NPC307895
0.8936 High Similarity NPC474939
0.8936 High Similarity NPC33653
0.8936 High Similarity NPC96216
0.8936 High Similarity NPC59522
0.8936 High Similarity NPC470909
0.8936 High Similarity NPC470553
0.8931 High Similarity NPC65041
0.8929 High Similarity NPC147688
0.8929 High Similarity NPC205006
0.8929 High Similarity NPC471640
0.8929 High Similarity NPC470555
0.8929 High Similarity NPC282300
0.8929 High Similarity NPC64908
0.8929 High Similarity NPC24075
0.8929 High Similarity NPC156590
0.8929 High Similarity NPC471644
0.8929 High Similarity NPC118840
0.8921 High Similarity NPC78913
0.8921 High Similarity NPC96565
0.8921 High Similarity NPC220062
0.8921 High Similarity NPC216978
0.8921 High Similarity NPC55018
0.8921 High Similarity NPC301217
0.8921 High Similarity NPC217186
0.8921 High Similarity NPC18260
0.8921 High Similarity NPC53181
0.8921 High Similarity NPC303633
0.8905 High Similarity NPC99854
0.8905 High Similarity NPC101752
0.8905 High Similarity NPC151113
0.8897 High Similarity NPC223354
0.8889 High Similarity NPC475589
0.8889 High Similarity NPC19238
0.8889 High Similarity NPC175159
0.8889 High Similarity NPC473584
0.8889 High Similarity NPC31872
0.8889 High Similarity NPC164299
0.8881 High Similarity NPC74539
0.8881 High Similarity NPC304443
0.8881 High Similarity NPC297886
0.8881 High Similarity NPC140120
0.8881 High Similarity NPC249942
0.8881 High Similarity NPC129650
0.8873 High Similarity NPC288910
0.8873 High Similarity NPC470554
0.8873 High Similarity NPC118059
0.8873 High Similarity NPC311741
0.8873 High Similarity NPC179970
0.8873 High Similarity NPC234629
0.8873 High Similarity NPC133060
0.8865 High Similarity NPC51146
0.8865 High Similarity NPC471643
0.8865 High Similarity NPC471639
0.8865 High Similarity NPC147145
0.8865 High Similarity NPC166858
0.8857 High Similarity NPC305355
0.8857 High Similarity NPC235239
0.8857 High Similarity NPC69769
0.8857 High Similarity NPC475680
0.8855 High Similarity NPC73413
0.8855 High Similarity NPC201667
0.8849 High Similarity NPC470671
0.8849 High Similarity NPC474504
0.8849 High Similarity NPC470672
0.8849 High Similarity NPC474487
0.8849 High Similarity NPC201395
0.8849 High Similarity NPC124269
0.8841 High Similarity NPC274109
0.8841 High Similarity NPC1486
0.8841 High Similarity NPC477243
0.8841 High Similarity NPC61546
0.8841 High Similarity NPC41461
0.8841 High Similarity NPC72452
0.8841 High Similarity NPC477244
0.8841 High Similarity NPC98115
0.8841 High Similarity NPC12165
0.8841 High Similarity NPC25287
0.8841 High Similarity NPC150399
0.8841 High Similarity NPC66349
0.8841 High Similarity NPC168105
0.8841 High Similarity NPC186838
0.8841 High Similarity NPC477242
0.8841 High Similarity NPC249606
0.8836 High Similarity NPC256141
0.8832 High Similarity NPC144027
0.8832 High Similarity NPC236974
0.8828 High Similarity NPC473466
0.8828 High Similarity NPC151973
0.8828 High Similarity NPC474735
0.8824 High Similarity NPC203817
0.8824 High Similarity NPC182428

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC268081 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.9197 High Similarity NPD1243 Approved
0.8978 High Similarity NPD2796 Approved
0.8881 High Similarity NPD920 Approved
0.8865 High Similarity NPD643 Clinical (unspecified phase)
0.8803 High Similarity NPD6799 Approved
0.8767 High Similarity NPD7411 Suspended
0.8741 High Similarity NPD642 Clinical (unspecified phase)
0.8741 High Similarity NPD4378 Clinical (unspecified phase)
0.8707 High Similarity NPD6801 Discontinued
0.8649 High Similarity NPD7096 Clinical (unspecified phase)
0.8649 High Similarity NPD7819 Suspended
0.8611 High Similarity NPD7410 Clinical (unspecified phase)
0.8571 High Similarity NPD6599 Discontinued
0.85 High Similarity NPD3748 Approved
0.8478 Intermediate Similarity NPD1240 Approved
0.8477 Intermediate Similarity NPD7075 Discontinued
0.8456 Intermediate Similarity NPD6832 Phase 2
0.8451 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.8451 Intermediate Similarity NPD1549 Phase 2
0.8421 Intermediate Similarity NPD919 Approved
0.8392 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.838 Intermediate Similarity NPD1552 Clinical (unspecified phase)
0.838 Intermediate Similarity NPD1550 Clinical (unspecified phase)
0.8369 Intermediate Similarity NPD1510 Phase 2
0.8357 Intermediate Similarity NPD1607 Approved
0.8333 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.8239 Intermediate Similarity NPD2799 Discontinued
0.8224 Intermediate Similarity NPD3817 Phase 2
0.8207 Intermediate Similarity NPD3750 Approved
0.8201 Intermediate Similarity NPD1296 Phase 2
0.82 Intermediate Similarity NPD4380 Phase 2
0.817 Intermediate Similarity NPD7768 Phase 2
0.8158 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.8153 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.8148 Intermediate Similarity NPD9717 Approved
0.8138 Intermediate Similarity NPD2800 Approved
0.8121 Intermediate Similarity NPD5403 Approved
0.8108 Intermediate Similarity NPD2534 Approved
0.8108 Intermediate Similarity NPD2533 Approved
0.8108 Intermediate Similarity NPD2532 Approved
0.8108 Intermediate Similarity NPD5401 Approved
0.8105 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.8099 Intermediate Similarity NPD6651 Approved
0.8082 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.8071 Intermediate Similarity NPD2313 Discontinued
0.8056 Intermediate Similarity NPD2935 Discontinued
0.8056 Intermediate Similarity NPD1551 Phase 2
0.8043 Intermediate Similarity NPD1019 Discontinued
0.8014 Intermediate Similarity NPD2654 Approved
0.8013 Intermediate Similarity NPD5494 Approved
0.8 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.8 Intermediate Similarity NPD3749 Approved
0.7971 Intermediate Similarity NPD3267 Approved
0.7971 Intermediate Similarity NPD3266 Approved
0.7971 Intermediate Similarity NPD1203 Approved
0.7941 Intermediate Similarity NPD422 Phase 1
0.7922 Intermediate Similarity NPD2801 Approved
0.7919 Intermediate Similarity NPD1511 Approved
0.7902 Intermediate Similarity NPD1899 Clinical (unspecified phase)
0.7901 Intermediate Similarity NPD5953 Discontinued
0.7888 Intermediate Similarity NPD7286 Phase 2
0.7857 Intermediate Similarity NPD1934 Approved
0.7848 Intermediate Similarity NPD1247 Approved
0.7832 Intermediate Similarity NPD4307 Phase 2
0.7821 Intermediate Similarity NPD3882 Suspended
0.7817 Intermediate Similarity NPD3268 Approved
0.7815 Intermediate Similarity NPD1512 Approved
0.781 Intermediate Similarity NPD1547 Clinical (unspecified phase)
0.7801 Intermediate Similarity NPD1008 Clinical (unspecified phase)
0.7778 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.7778 Intermediate Similarity NPD3226 Approved
0.7778 Intermediate Similarity NPD5124 Phase 1
0.7778 Intermediate Similarity NPD5123 Clinical (unspecified phase)
0.7778 Intermediate Similarity NPD1933 Approved
0.7763 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.7756 Intermediate Similarity NPD5402 Approved
0.7736 Intermediate Similarity NPD6959 Discontinued
0.7718 Intermediate Similarity NPD4628 Phase 3
0.7718 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.7714 Intermediate Similarity NPD2797 Approved
0.7707 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.7688 Intermediate Similarity NPD6232 Discontinued
0.7677 Intermediate Similarity NPD5890 Approved
0.7677 Intermediate Similarity NPD5889 Approved
0.7669 Intermediate Similarity NPD1241 Discontinued
0.7669 Intermediate Similarity NPD5844 Phase 1
0.766 Intermediate Similarity NPD2798 Approved
0.7654 Intermediate Similarity NPD7473 Discontinued
0.764 Intermediate Similarity NPD3926 Phase 2
0.7635 Intermediate Similarity NPD2346 Discontinued
0.7626 Intermediate Similarity NPD3972 Approved
0.7619 Intermediate Similarity NPD4308 Phase 3
0.7619 Intermediate Similarity NPD7033 Discontinued
0.7613 Intermediate Similarity NPD6585 Discontinued
0.7607 Intermediate Similarity NPD3818 Discontinued
0.7569 Intermediate Similarity NPD411 Approved
0.7536 Intermediate Similarity NPD17 Approved
0.7534 Intermediate Similarity NPD447 Suspended
0.753 Intermediate Similarity NPD6559 Discontinued
0.7518 Intermediate Similarity NPD3225 Approved
0.7518 Intermediate Similarity NPD9545 Approved
0.7517 Intermediate Similarity NPD2344 Approved
0.75 Intermediate Similarity NPD7893 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD9493 Approved
0.7485 Intermediate Similarity NPD7784 Clinical (unspecified phase)
0.7485 Intermediate Similarity NPD4419 Clinical (unspecified phase)
0.7485 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.7485 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.7485 Intermediate Similarity NPD6166 Phase 2
0.7469 Intermediate Similarity NPD5711 Approved
0.7469 Intermediate Similarity NPD5710 Approved
0.7455 Intermediate Similarity NPD7054 Approved
0.7434 Intermediate Similarity NPD3887 Approved
0.7421 Intermediate Similarity NPD4288 Approved
0.7415 Intermediate Similarity NPD230 Phase 1
0.741 Intermediate Similarity NPD7472 Approved
0.741 Intermediate Similarity NPD7074 Phase 3
0.74 Intermediate Similarity NPD2355 Clinical (unspecified phase)
0.74 Intermediate Similarity NPD2353 Approved
0.7383 Intermediate Similarity NPD1509 Clinical (unspecified phase)
0.7381 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.7378 Intermediate Similarity NPD2403 Approved
0.7376 Intermediate Similarity NPD1608 Approved
0.7371 Intermediate Similarity NPD8090 Clinical (unspecified phase)
0.7365 Intermediate Similarity NPD6797 Phase 2
0.7358 Intermediate Similarity NPD1465 Phase 2
0.7347 Intermediate Similarity NPD3140 Approved
0.7347 Intermediate Similarity NPD3142 Approved
0.7342 Intermediate Similarity NPD7615 Clinical (unspecified phase)
0.7333 Intermediate Similarity NPD6099 Approved
0.7333 Intermediate Similarity NPD5535 Approved
0.7333 Intermediate Similarity NPD6100 Approved
0.7328 Intermediate Similarity NPD9697 Approved
0.7321 Intermediate Similarity NPD7251 Discontinued
0.732 Intermediate Similarity NPD2309 Approved
0.7303 Intermediate Similarity NPD1652 Phase 2
0.7285 Intermediate Similarity NPD1471 Phase 3
0.7285 Intermediate Similarity NPD2343 Clinical (unspecified phase)
0.7278 Intermediate Similarity NPD7808 Phase 3
0.7262 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.7256 Intermediate Similarity NPD6808 Phase 2
0.7244 Intermediate Similarity NPD2186 Approved
0.7244 Intermediate Similarity NPD5049 Phase 3
0.723 Intermediate Similarity NPD943 Approved
0.7219 Intermediate Similarity NPD6104 Discontinued
0.7215 Intermediate Similarity NPD7458 Discontinued
0.7214 Intermediate Similarity NPD5691 Approved
0.7211 Intermediate Similarity NPD6798 Discontinued
0.7211 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.7208 Intermediate Similarity NPD2354 Approved
0.7205 Intermediate Similarity NPD5353 Approved
0.7202 Intermediate Similarity NPD1729 Discontinued
0.7176 Intermediate Similarity NPD9261 Approved
0.7153 Intermediate Similarity NPD1876 Approved
0.7152 Intermediate Similarity NPD7229 Phase 3
0.7143 Intermediate Similarity NPD3134 Approved
0.7143 Intermediate Similarity NPD7003 Approved
0.7143 Intermediate Similarity NPD1548 Phase 1
0.7115 Intermediate Similarity NPD7390 Discontinued
0.7108 Intermediate Similarity NPD5242 Approved
0.7107 Intermediate Similarity NPD5808 Clinical (unspecified phase)
0.7105 Intermediate Similarity NPD4477 Approved
0.7105 Intermediate Similarity NPD4476 Approved
0.7103 Intermediate Similarity NPD1164 Approved
0.7095 Intermediate Similarity NPD1699 Clinical (unspecified phase)
0.709 Intermediate Similarity NPD1358 Approved
0.7081 Intermediate Similarity NPD6280 Approved
0.7081 Intermediate Similarity NPD6279 Approved
0.7075 Intermediate Similarity NPD4908 Phase 1
0.707 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7067 Intermediate Similarity NPD6355 Discontinued
0.7063 Intermediate Similarity NPD1281 Approved
0.7062 Intermediate Similarity NPD4363 Phase 3
0.7062 Intermediate Similarity NPD4360 Phase 2
0.7059 Intermediate Similarity NPD6006 Clinical (unspecified phase)
0.7059 Intermediate Similarity NPD6004 Phase 3
0.7059 Intermediate Similarity NPD6003 Clinical (unspecified phase)
0.7059 Intermediate Similarity NPD6002 Phase 3
0.7059 Intermediate Similarity NPD6005 Phase 3
0.7051 Intermediate Similarity NPD6652 Clinical (unspecified phase)
0.7047 Intermediate Similarity NPD8032 Phase 2
0.7042 Intermediate Similarity NPD1778 Approved
0.7042 Intermediate Similarity NPD4626 Approved
0.7029 Intermediate Similarity NPD4287 Approved
0.7025 Intermediate Similarity NPD6273 Approved
0.7022 Intermediate Similarity NPD4361 Phase 2
0.7022 Intermediate Similarity NPD4362 Clinical (unspecified phase)
0.7021 Intermediate Similarity NPD1894 Discontinued
0.7012 Intermediate Similarity NPD6971 Discontinued
0.7006 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.7006 Intermediate Similarity NPD7837 Clinical (unspecified phase)
0.7 Intermediate Similarity NPD2979 Phase 3
0.7 Intermediate Similarity NPD8158 Clinical (unspecified phase)
0.6993 Remote Similarity NPD5404 Approved
0.6993 Remote Similarity NPD5406 Approved
0.6993 Remote Similarity NPD5408 Approved
0.6993 Remote Similarity NPD5405 Approved
0.6988 Remote Similarity NPD7199 Phase 2
0.6987 Remote Similarity NPD3295 Clinical (unspecified phase)
0.698 Remote Similarity NPD3764 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data